RT Journal Article
SR Electronic
T1 Assessing the Impact of use of HIV self-testing on the incidence of HIV Infection in Nigeria: a systematic review and meta-analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.04.24305344
DO 10.1101/2024.04.04.24305344
A1 Eleje, George Uchenna
A1 Emmanuel, Godwin Omokhagbo
A1 Akinsolu, Folahanmi Tomiwa
A1 Foláyan, Morẹ́nikẹ́ Oluwátóyìn
YR 2024
UL http://medrxiv.org/content/early/2024/04/06/2024.04.04.24305344.abstract
AB Background Human immunodeficiency virus (HIV) self-testing tool is a widely adopted tool in Nigeria. However, there is little known about its impact in reducing HIV infection rates in Nigeria. This review aims to assess the impact of the use of HIV self-testing on the incidence of HIV infections in the country.Methods This was a systematic review and meta-analysis. Studies conducted in Nigeria on HIV self- testing with or without comparison to other HIV tests were included. The primary outcomes considered were the detection rate of new HIV cases and the acceptability (uptake) rate for HIV self-testing. Secondary outcomes were the usability rate, repeat testing rate, willingness rate, awareness rate, incidence of social harm, and incidence of high-risk behaviour. Electronic databases (PubMed/Medline, Web of Science, Scopus, CINAHL, and Cochrane Library) and Google Scholar were searched for relevant studies. Searches were conducted till December 2, 2023. Pooled estimates were calculated using a random-effects model with the DerSimonian Laird method. Heterogeneity was analyzed using the I2 test, and risk of bias was assessed with the Hoy and colleagues’ scale. Meta-analysis was conducted where possible. The protocol was registered with PROSPERO (CRD42023479752).Results Eight studies, encompassing 7,556 participants, met the inclusion criteria. The overall risk of bias for the included studies was adjudged low. The detection rate of HIV self-testing for new HIV cases was 25.78% (95% CI: 0.90-50.66, I2:100.0), acceptability (uptake) rate was 56.92% (95% CI: 26.54-87.30, I2:100.0), and repeat testing rate was 20.10% (95% CI: -11.44-51.65, I2:100.0). Usability rate, willingness rate, awareness rate, and incidence of high-risk behaviour were reported in one study respectively, with no information on the incidence of social harm. Sensitivity analysis was done, and subgroup analyses could not be estimated due to insufficient data.Conclusions The use of HIV self-testing test kits in Nigeria showed a high detection rate of new HIV cases, moderate acceptability, but low repeat testing rates. However, the evidence is limited. Larger, higher-quality studies are essential to explore the broader impact of HIV self-testing on reducing HIV incidence in Nigeria.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not applicable because it is a systematic review of primary studies.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableAll data underlying the results are available as part of the article and its accompanying data document.